Abstract
Purpose of Review
Cogan’s syndrome (CS) is a rare systemic vasculitis that can severely affect vision and hearing, which may also have significant systemic effects. Early recognition of this autoimmune disorder and intervention can minimize disabling and irreversible damage.
Recent Findings
This article will review the varying clinical presentations of CS and emerging information of systemic disease associated with CS. We will also review recently published promising treatment outcomes using immune modulating medications.
Summary
As our framework for recognizing the markers of CS and the associated systemic disorders expands, more effective guidelines and treatment options may emerge.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine. 1980;59:426–41.
Vollertsen RS, McDonald TJ, Younge BR, et al. Cogan’s syndrome: 18 cases and a review of the literature. Mayo Clin Proc. 1986;61:344–61. https://doi.org/10.1016/s0025-6196(12)61951-x.
Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc. 2006;81:483–8. https://doi.org/10.4065/81.4.483.
Mora P, Calzetti G, Ghirardini S, et al. Cogan’s syndrome: state of the art of systemic immunosuppressive treatment in adult and pediatric patients. Autoimmun Rev. 2017;16:385–90. https://doi.org/10.1016/j.autrev.2017.02.009Systematic review of combination therapy for Cogan’s syndrome.
Durtette C, Hachulla E, Resche-Rigon M, et al. Cogan syndrome: characteristics, outcome and treatment in a French nationwide retrospective study and literature review. Autoimmun Rev. 2017;16:1219–23. https://doi.org/10.1016/j.autrev.2017.10.005Most recent large (62 patients) retrospective review of Cogan’s syndrome with comparison data regarding therapeutic agents.
Morgan RF, Baumgartner CJ. Meniere’s disease complicated by recurrent interstitial keratitis: excellent result following cervical ganglionectomy. West J Surg. 1934;42:628.
Cogan DG. Syndrome of non-syphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol. 1945;33:144–9.
Greco A, Gallo A, Fusconi M, Magliulo G, Turchetta R, Marinelli C, et al. Cogan’s syndrome: an autoimmune inner ear disease. Autoimmun Rev. 2013;12:396–400. https://doi.org/10.1016/j.autrev.2012.07.012.
Kessel A, Vadasz Z, Toubi E. Cogan syndrome – pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2014;13:351–4. https://doi.org/10.1016/j.autrev.2014.01.002.
Lunardi C, Bason C, Leandri M, Navone R, Lestani M, Millo E, et al. Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet. 2002;360:915–21. https://doi.org/10.1016/S0140-6736(02)11028-2.
Jung DH, Nadol JB Jr, Folkerth RD, Merola JF. Histopathology of the inner ear in a case with recent onset of Cogan’s syndrome: evidence for vasculitis. Ann Otol Rhinol Laryngol. 2016;125:20–4. https://doi.org/10.1177/0003489415595426.
Grasland A, Pouchot J, Hachulla E, Blétry O, Papo T, Vinceneux P, et al. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology. 2004;43:1007–15. https://doi.org/10.1093/rheumatology/keh228.
Espinoza GM, Prost A. Cogan’s syndrome and other ocular vasculitides. Curr Rheumatol Rep. 2015;17:24. https://doi.org/10.1007/s11926-015-0499-y.
Shahid FL, Mukherjee R, Knapp C. Cogan’s syndrome associated with orbital inflammation. Orbit. 2013;32:206–7. https://doi.org/10.3109/01676830.2013.764324.
Singer JR, Reddy RK. Serous neurosensory retinal detachment associated with atypical Cogan syndrome: a case report. Retin Cases Brief Rep. 2015;9:315–9. https://doi.org/10.1097/ICB.0000000000000201.
Colodetti R, Spina G, Leal T, et al. Cogan’s syndrome – a rare aortitis, difficult to diagnose but with therapeutic potential. Rev Assoc Med Bras (1992). 2017;63:1028–31. https://doi.org/10.1590/1806-9282.63.12.1028Important description of the most common systemic vascular complication of Cogan’s syndrome.
Shamriz O, Tal Y, Gross M. Autoimmune inner ear disease: immune biomarkers, audiovestibular aspects, and therapeutic modalities of Cogan’s syndrome. J Immunol Res. 2018;2018:1498640–8. https://doi.org/10.1155/2018/1498640.
Vavricka SR, Greuter T, Scharl M, Mantzaris G, Shitrit AB, Filip R, et al. Cogan’s syndrome in patients with inflammatory bowel disease – a case series. J Crohns Colitis. 2015;9:886–90. https://doi.org/10.1093/ecco-jcc/jjv128.
Scharl M, Frei P, Fried M, Rogler G, Vavricka SR. Association between Cogan’s syndrome and inflammatory bowel disease: a case series. J Crohns Colitis. 2011;5:64–8. https://doi.org/10.1016/j.crohns.2010.09.003.
Branislava I, Marijana T, Nemanja D, Dragan S, Maja Z. Atypical Cogan’s syndrome associated with coronary disease. Chin Med J. 2011;124:3192–4.
Gaubitz M, Lubben B, Seidel M, et al. Cogan’s syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol. 2001;19:463–9.
Gasparovic H, Djuric Z, Bosnic D, Petricevic M, Brida M, Dotlic S, et al. Aortic root vasculitis associated with Cogan’s syndrome. Ann Thorac Surg. 2011;92:340–1. https://doi.org/10.1016/j.athoracsur.2010.12.068.
Hautefort C, Loundon N, Montchilova M, Marlin S, Garabedian EN, Ulinski T. Mycophenolate mofetil as a treatment of steroid dependent Cogan’s syndrome in childhood. Int J Pediatr Otorhinolaryngol. 2009;73:1477–9. https://doi.org/10.1016/j.ijporl.2009.06.025.
Pagnini I, Zannin ME, Vittadello F, Sari M, Simonini G, Cimaz R, et al. Clinical features and outcome of Cogan syndrome. J Pediatr. 2012;160:303–7. https://doi.org/10.1016/jpeds.2011.07.051.
Sakano H, Harris JP. Emerging options in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol. 2018;4:102–8. https://doi.org/10.1002/lio2.205Nicely delineated treatment options for autoimmune inflammation of the inner ear that is a hallmark of Cogan’s syndrome.
Padoan R, Cazzador D, Pendolino AL, et al. Cogan’s syndrome: new therapeutic approaches in the biological era. Expert Opin Biol Ther. 2019;19:781–8. https://doi.org/10.1080/14712598.2019.1611779Comprehensive review of rising role of biologic agents in the treatment of Cogan’s syndrome.
Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, Mcdonald TJ, et al. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum. 2005;53:337–42. https://doi.org/10.1002/art.21179.
Shibuya M, Fujio K, Morita K, Harada H, Kanda H, Yamamoto K. Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis. Mod Rheumatol. 2013;23:577–81. https://doi.org/10.1007/s10165-012-0691-0.
Vollersten R. Vasculitis and Cogan’s syndrome. Rheum Dis Clin N Am. 1990;16:433–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflict of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Autoimmunity
Rights and permissions
About this article
Cite this article
Espinoza, G.M., Wheeler, J., Temprano, K.K. et al. Cogan’s Syndrome: Clinical Presentations and Update on Treatment. Curr Allergy Asthma Rep 20, 46 (2020). https://doi.org/10.1007/s11882-020-00945-1
Published:
DOI: https://doi.org/10.1007/s11882-020-00945-1